Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
McKesson
Healthtrust
Teva
Citi
Daiichi Sankyo
Mallinckrodt
Deloitte
US Army

Generated: April 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,134,127

« Back to Dashboard

Summary for Patent: 5,134,127
Title: Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
Abstract:Sulfoalkyl ether cyclodextrin derivatives and their use as solubilizing agents for water insoluble drugs for oral, intranasal, or parenteral administration are disclosed.
Inventor(s): Stella; Valentino (Lawrence, KS), Rajewski; Roger (Lawrence, KS)
Assignee: University of Kansas (Lawrence, KS)
Application Number:07/469,087
Patent Claim Types:
see list of patent claims
Composition; Compound;

Drugs Protected by US Patent 5,134,127

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,134,127

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 7236491 ➤ Try a Free Trial
Canada 2074186 ➤ Try a Free Trial
Canada 2119154 ➤ Try a Free Trial
Germany 69130165 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Chubb
Moodys
Mallinckrodt
Harvard Business School
Accenture
Merck
QuintilesIMS
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.